Over the past decade, enormous progress has been made in both the technical approaches
and the scientific information available for studying the human genome. Therefore,
increasingly, scientists have begun to address not just single‐gene disorders but complex
disorders. The limiting factor in most of such studies remains appropriate, well‐focused
detailed phenotyping of the complex disorders under study, with careful ascertainment of
subjects with the specific disorder, as well as healthy control subjects. Clinical …